CN101623278A - 一种含有左旋多巴和盐酸苄丝肼的药物组合物 - Google Patents
一种含有左旋多巴和盐酸苄丝肼的药物组合物 Download PDFInfo
- Publication number
- CN101623278A CN101623278A CN 200810116328 CN200810116328A CN101623278A CN 101623278 A CN101623278 A CN 101623278A CN 200810116328 CN200810116328 CN 200810116328 CN 200810116328 A CN200810116328 A CN 200810116328A CN 101623278 A CN101623278 A CN 101623278A
- Authority
- CN
- China
- Prior art keywords
- levodopa
- pharmaceutical composition
- carrier
- pharmaceutically acceptable
- benserazide hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BNQDCRGUHNALGH-UHFFFAOYSA-N benserazide Chemical compound OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O BNQDCRGUHNALGH-UHFFFAOYSA-N 0.000 title claims abstract description 40
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title claims abstract description 31
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229960004502 levodopa Drugs 0.000 title claims abstract description 28
- 229960001335 benserazide hydrochloride Drugs 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 title claims abstract description 12
- 239000003937 drug carrier Substances 0.000 claims abstract description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 16
- -1 hydroxypropyl Chemical group 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000007500 overflow downdraw method Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Polymers CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 claims description 2
- NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 235000011194 food seasoning agent Nutrition 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 238000005498 polishing Methods 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 206010034010 Parkinsonism Diseases 0.000 abstract description 7
- 208000027089 Parkinsonian disease Diseases 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 229960003638 dopamine Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003360 nephrocyte Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- IVTMXOXVAHXCHI-YXLMWLKOSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;(2s)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 IVTMXOXVAHXCHI-YXLMWLKOSA-N 0.000 description 1
- 229940123736 Decarboxylase inhibitor Drugs 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000008039 Secondary Parkinson Disease Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960000911 benserazide Drugs 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003954 decarboxylase inhibitor Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
1个月 | 2个月 | 3个月 | 6个月 | |
实施例1 | - | - | - | - |
实施例2 | - | - | - | - |
实施例3 | - | - | - | - |
对比实施例 | - | - | + | ++ |
0个月 | 3个月 | 6个月 | 9个月 | 12个月 | 18个月 | |
实施例1 | - | - | - | - | - | - |
实施例2 | - | - | - | - | - | - |
实施例3 | - | - | - | - | - | - |
对比实施例 | - | - | - | + | + | ++ |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810116328 CN101623278B (zh) | 2008-07-09 | 2008-07-09 | 一种含有左旋多巴和盐酸苄丝肼的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810116328 CN101623278B (zh) | 2008-07-09 | 2008-07-09 | 一种含有左旋多巴和盐酸苄丝肼的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101623278A true CN101623278A (zh) | 2010-01-13 |
CN101623278B CN101623278B (zh) | 2013-02-27 |
Family
ID=41519373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810116328 Active CN101623278B (zh) | 2008-07-09 | 2008-07-09 | 一种含有左旋多巴和盐酸苄丝肼的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101623278B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101797244A (zh) * | 2010-04-01 | 2010-08-11 | 青岛科技大学 | 一种多巴丝肼口腔崩解片 |
WO2012009973A1 (zh) * | 2010-07-20 | 2012-01-26 | 上海交通大学医学院附属新华医院 | 一种含有抗帕金森病药物的微球组合药物及其应用 |
CN102885804A (zh) * | 2011-07-20 | 2013-01-23 | 上海信谊药厂有限公司 | 多巴胺前体药物组合物及其制备方法 |
CN103385871A (zh) * | 2012-05-07 | 2013-11-13 | 新疆医科大学 | 复方左旋多巴微囊漂浮片 |
CN103948579A (zh) * | 2013-11-04 | 2014-07-30 | 江苏大学 | 左旋多巴/盐酸苄丝肼复方缓释混悬剂及其制备方法 |
CN106074474A (zh) * | 2016-06-15 | 2016-11-09 | 中南大学湘雅医院 | 羟苄丝肼及其在药学上可接受的盐在制备抗肿瘤药物方面的应用 |
CN113081994A (zh) * | 2021-04-20 | 2021-07-09 | 杭州泓友医药科技有限公司 | 一种用于治疗帕金森症的复方药物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105078952A (zh) * | 2015-08-10 | 2015-11-25 | 中国康复研究中心 | 一种左旋多巴制剂及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5354885A (en) * | 1992-12-24 | 1994-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Process for preparing ethyl ester of L-DOPA |
CN100478327C (zh) * | 2006-11-15 | 2009-04-15 | 蒋伟哲 | 左旋多巴甲酯盐酸盐的制备方法 |
-
2008
- 2008-07-09 CN CN 200810116328 patent/CN101623278B/zh active Active
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101797244A (zh) * | 2010-04-01 | 2010-08-11 | 青岛科技大学 | 一种多巴丝肼口腔崩解片 |
CN101797244B (zh) * | 2010-04-01 | 2012-07-04 | 青岛科技大学 | 一种多巴丝肼口腔崩解片 |
WO2012009973A1 (zh) * | 2010-07-20 | 2012-01-26 | 上海交通大学医学院附属新华医院 | 一种含有抗帕金森病药物的微球组合药物及其应用 |
CN102885804A (zh) * | 2011-07-20 | 2013-01-23 | 上海信谊药厂有限公司 | 多巴胺前体药物组合物及其制备方法 |
CN102885804B (zh) * | 2011-07-20 | 2015-09-02 | 上海信谊药厂有限公司 | 多巴胺前体药物组合物及其制备方法 |
CN103385871A (zh) * | 2012-05-07 | 2013-11-13 | 新疆医科大学 | 复方左旋多巴微囊漂浮片 |
CN103385871B (zh) * | 2012-05-07 | 2017-06-23 | 新疆医科大学 | 复方左旋多巴微囊漂浮片 |
CN103948579A (zh) * | 2013-11-04 | 2014-07-30 | 江苏大学 | 左旋多巴/盐酸苄丝肼复方缓释混悬剂及其制备方法 |
CN106074474A (zh) * | 2016-06-15 | 2016-11-09 | 中南大学湘雅医院 | 羟苄丝肼及其在药学上可接受的盐在制备抗肿瘤药物方面的应用 |
CN113081994A (zh) * | 2021-04-20 | 2021-07-09 | 杭州泓友医药科技有限公司 | 一种用于治疗帕金森症的复方药物及其制备方法 |
CN114159417A (zh) * | 2021-04-20 | 2022-03-11 | 杭州泓友医药科技有限公司 | 一种用于治疗帕金森症的复方药物及其制备方法 |
CN114224878A (zh) * | 2021-04-20 | 2022-03-25 | 杭州泓友医药科技有限公司 | 一种用于治疗帕金森症的复方药物 |
Also Published As
Publication number | Publication date |
---|---|
CN101623278B (zh) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101623278B (zh) | 一种含有左旋多巴和盐酸苄丝肼的药物组合物 | |
US11826373B2 (en) | Methods for treatment of diseases | |
CN104434931A (zh) | 含替格瑞洛和阿司匹林的复方口服固体剂及其制备方法 | |
CN1568999A (zh) | 稳定的医药用河豚毒素冷冻干燥制剂 | |
CN101461798A (zh) | 一种含有二氯醋酸二异丙胺的口服药物组合物 | |
CN104940160A (zh) | 改进的磷酸奥司他韦固体组合物及其制备方法 | |
CN101757623B (zh) | 一种5-ht受体激动剂固体药物组合物 | |
CN103720666B (zh) | 一种注射用硼替佐米冻干制剂的制备方法 | |
CN103142583A (zh) | 含有左乙拉西坦的药物组合物及其制备方法 | |
CN1843331A (zh) | 一种含抗生素的缓释剂及其应用 | |
CN102485232A (zh) | 一种含地西他滨的药物组合物 | |
CN102429883A (zh) | 盐酸氟西汀口腔崩解药物组合物 | |
CN106540265A (zh) | 一种奥格列汀药物组合物及其制备方法 | |
CN1879604A (zh) | 一种含抗生素的缓释注射剂及其应用 | |
CN100358506C (zh) | 复方麝香滴丸及其制备方法 | |
CN103877073B (zh) | 一种斑蝥酸钠控释制剂及其制备方法 | |
CN100341511C (zh) | 伊曲康唑滴丸及其制备方法 | |
CN102335137A (zh) | 一种含美罗培南的药物组合物 | |
CN1879620A (zh) | 一种含青霉素类抗生素的缓释注射剂及其应用 | |
CN1307981C (zh) | 一种具有止血作用的血宁滴丸及其制备方法 | |
CN104434932B (zh) | 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法 | |
CN1307982C (zh) | 一种用于降血脂的脉舒滴丸及其制备方法 | |
CN1843336A (zh) | 一种含青霉素类抗生素的缓释剂及其应用 | |
CN1973824A (zh) | 同载铂类化合物和雷帕霉素的抗癌组合物 | |
CN1887257A (zh) | 同载铂类化合物和克罗拉滨的抗癌药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201126 Address after: No. 279 Nanhai Road, Xiuying District 570314 Hainan city of Haikou Province Patentee after: AVENTIS PHARMA (HAINAN) Co.,Ltd. Address before: 100097, Wanquan mansion, 3 Jin Zhuang, Haidian District, Beijing, Sijiqing Patentee before: BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Song Xuemei Document name: Notice of conformity |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A drug combination containing levodopa and benzylhydrazine hydrochloride Granted publication date: 20130227 Pledgee: Sanya Rural Commercial Bank Co.,Ltd. Pledgor: AVENTIS PHARMA (HAINAN) Co.,Ltd. Registration number: Y2024980014810 |